EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
13th December 2024 Uncategorised 0 EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
aliu
Fri, 12/13/2024 – 10:41
More: EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from .3B deal
Source: fierce